Altium Capital Management LLC / BBIO
Altium Capital Management LLC’s Bridgebio Pharma Inc Position
Does Altium Capital Management LLC own Bridgebio Pharma Inc (BBIO)? Not currently — the last reported position was 155.0K shares worth $3M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q1 2023
Shares
155.0K
% of Portfolio
+1.43%
Quarters Held
2
position exited
Position History BBIO
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of BBIO.